These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2074337)

  • 21. [Immunostimulating and antitumor action of psychotropic preparations of the sydnonimine series].
    Veksler IG; Riabukha VN; Balitskiĭ KP; Al'tshuler RA; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(3):349-52. PubMed ID: 7449977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inappropriate drug use in the elderly: a nationwide register-based study.
    Johnell K; Fastbom J; Rosén M; Leimanis A
    Ann Pharmacother; 2007 Jul; 41(7):1243-8. PubMed ID: 17595305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characterization of drug, narcotic and psychotropic drug chirality by statistical methods].
    Noszál B; Schiller Z
    Acta Pharm Hung; 1999 Apr; 69(2):85-90. PubMed ID: 10389303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From genomics to drug targets.
    Dahl SG; Sylte I
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):95-9. PubMed ID: 16785277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulatory effect of neurotransmitters and neurotropic drugs on the release of 3H-D-aspartic acid from synaptosomes.
    Rayevsky KS; Kovalev GI; Prikhozhan AV
    Ann Ist Super Sanita; 1988; 24(3):383-8. PubMed ID: 2903706
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sleep stages in man--physiological profile and variations induced by psychotropic drugs].
    Gaillard JM
    Schweiz Rundsch Med Prax; 1988 Aug; 77(33):844-8. PubMed ID: 2902680
    [No Abstract]   [Full Text] [Related]  

  • 27. Ethanol-psychotropic drug interactions: pharmacokinetics.
    Sellers EM
    Psychopharmacol Bull; 1984; 20(3):497-9. PubMed ID: 6473655
    [No Abstract]   [Full Text] [Related]  

  • 28. [The psychotropic effects of thymogen].
    Nevidimova TI; Suslov NI
    Biull Eksp Biol Med; 1995 Feb; 119(2):199-200. PubMed ID: 7670053
    [No Abstract]   [Full Text] [Related]  

  • 29. Opiates as immunocompromising drugs: the evidence and possible mechanisms.
    Donahoe R
    NIDA Res Monogr; 1988; 90():105-14. PubMed ID: 2855849
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs.
    Di Giovanni G; Di Matteo V; Esposito E
    Indian J Exp Biol; 2002 Dec; 40(12):1344-52. PubMed ID: 12974395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
    Melzacka M
    Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Endogenous ligands" of benzodiazepine receptors, their structural analogs. Development of new psychotropic drugs.
    Akhundov RA; Voronina TA; Valdman AV
    Acta Physiol Pharmacol Bulg; 1985; 11(4):3-11. PubMed ID: 3012945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropic drugs and the thyroid axis: a review of interactions.
    Prange AJ
    Adv Biochem Psychopharmacol; 1985; 40():103-10. PubMed ID: 3895837
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacological effects of combinations of psychotropic preparations used in combined pharmacotherapy].
    Zimakova IE; Baĭchurina AZ; Zimakov IuA
    Farmakol Toksikol; 1987; 50(1):8-10. PubMed ID: 3556558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avoiding psychotropic drug interactions in the cardiovascular patient.
    DeVane CL; Markowitz JS
    Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic drug monitoring and drug-drug interactions: a pharmacoepidemiological perspective.
    Balant-Gorgia AE; Gex-Fabry M; Balant LP
    Therapie; 1996; 51(4):399-402. PubMed ID: 8953816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Metabolic drug interactions -- a pyschiatrist's viewpoint.
    Marriot P
    Med J Aust; 1975 Jul; 2(1):33. PubMed ID: 1160713
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucocorticoids and vulnerability to psychostimulant drugs: toward substrate and mechanism.
    de Jong IE; de Kloet ER
    Ann N Y Acad Sci; 2004 Jun; 1018():192-8. PubMed ID: 15240368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology.
    Donovan JL; DeVane CL
    Psychopharmacol Bull; 2001; 35(3):30-48. PubMed ID: 12397877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.